FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206616002> ?p ?o ?g. }

• W4206616002 endingPage "79.e11" @default.
• W4206616002 startingPage "79.e1" @default.
• W4206616002 abstract "BackgroundHistorically, prenatal screening has focused primarily on the detection of fetal aneuploidies. Cell-free DNA now enables noninvasive screening for subchromosomal copy number variants, including 22q11.2 deletion syndrome (or DiGeorge syndrome), which is the most common microdeletion and a leading cause of congenital heart defects and neurodevelopmental delay. Although smaller studies have demonstrated the feasibility of screening for 22q11.2 deletion syndrome, large cohort studies with confirmatory postnatal testing to assess test performance have not been reported.ObjectiveThis study aimed to assess the performance of single-nucleotide polymorphism–based, prenatal cell-free DNA screening for detection of 22q11.2 deletion syndrome.Study DesignPatients who underwent single-nucleotide polymorphism–based prenatal cell-free DNA screening for 22q11.2 deletion syndrome were prospectively enrolled at 21 centers in 6 countries. Prenatal or newborn DNA samples were requested in all cases for genetic confirmation using chromosomal microarrays. The primary outcome was sensitivity, specificity, positive predictive value, and negative predictive value of cell-free DNA screening for the detection of all deletions, including the classical deletion and nested deletions that are ≥500 kb, in the 22q11.2 low-copy repeat A-D region. Secondary outcomes included the prevalence of 22q11.2 deletion syndrome and performance of an updated cell-free DNA algorithm that was evaluated with blinding to the pregnancy outcome.ResultsOf the 20,887 women enrolled, a genetic outcome was available for 18,289 (87.6%). A total of 12 22q11.2 deletion syndrome cases were confirmed in the cohort, including 5 (41.7%) nested deletions, yielding a prevalence of 1 in 1524. In the total cohort, cell-free DNA screening identified 17,976 (98.3%) cases as low risk for 22q11.2 deletion syndrome and 38 (0.2%) cases as high risk; 275 (1.5%) cases were nonreportable. Overall, 9 of 12 cases of 22q11.2 were detected, yielding a sensitivity of 75.0% (95% confidence interval, 42.8–94.5); specificity of 99.84% (95% confidence interval, 99.77–99.89); positive predictive value of 23.7% (95% confidence interval, 11.44–40.24), and negative predictive value of 99.98% (95% confidence interval, 99.95–100). None of the cases with a nonreportable result was diagnosed with 22q11.2 deletion syndrome. The updated algorithm detected 10 of 12 cases (83.3%; 95% confidence interval, 51.6–97.9) with a lower false positive rate (0.05% vs 0.16%; P<.001) and a positive predictive value of 52.6% (10/19; 95% confidence interval, 28.9–75.6).ConclusionNoninvasive cell-free DNA prenatal screening for 22q11.2 deletion syndrome can detect most affected cases, including smaller nested deletions, with a low false positive rate. Historically, prenatal screening has focused primarily on the detection of fetal aneuploidies. Cell-free DNA now enables noninvasive screening for subchromosomal copy number variants, including 22q11.2 deletion syndrome (or DiGeorge syndrome), which is the most common microdeletion and a leading cause of congenital heart defects and neurodevelopmental delay. Although smaller studies have demonstrated the feasibility of screening for 22q11.2 deletion syndrome, large cohort studies with confirmatory postnatal testing to assess test performance have not been reported. This study aimed to assess the performance of single-nucleotide polymorphism–based, prenatal cell-free DNA screening for detection of 22q11.2 deletion syndrome. Patients who underwent single-nucleotide polymorphism–based prenatal cell-free DNA screening for 22q11.2 deletion syndrome were prospectively enrolled at 21 centers in 6 countries. Prenatal or newborn DNA samples were requested in all cases for genetic confirmation using chromosomal microarrays. The primary outcome was sensitivity, specificity, positive predictive value, and negative predictive value of cell-free DNA screening for the detection of all deletions, including the classical deletion and nested deletions that are ≥500 kb, in the 22q11.2 low-copy repeat A-D region. Secondary outcomes included the prevalence of 22q11.2 deletion syndrome and performance of an updated cell-free DNA algorithm that was evaluated with blinding to the pregnancy outcome. Of the 20,887 women enrolled, a genetic outcome was available for 18,289 (87.6%). A total of 12 22q11.2 deletion syndrome cases were confirmed in the cohort, including 5 (41.7%) nested deletions, yielding a prevalence of 1 in 1524. In the total cohort, cell-free DNA screening identified 17,976 (98.3%) cases as low risk for 22q11.2 deletion syndrome and 38 (0.2%) cases as high risk; 275 (1.5%) cases were nonreportable. Overall, 9 of 12 cases of 22q11.2 were detected, yielding a sensitivity of 75.0% (95% confidence interval, 42.8–94.5); specificity of 99.84% (95% confidence interval, 99.77–99.89); positive predictive value of 23.7% (95% confidence interval, 11.44–40.24), and negative predictive value of 99.98% (95% confidence interval, 99.95–100). None of the cases with a nonreportable result was diagnosed with 22q11.2 deletion syndrome. The updated algorithm detected 10 of 12 cases (83.3%; 95% confidence interval, 51.6–97.9) with a lower false positive rate (0.05% vs 0.16%; P<.001) and a positive predictive value of 52.6% (10/19; 95% confidence interval, 28.9–75.6). Noninvasive cell-free DNA prenatal screening for 22q11.2 deletion syndrome can detect most affected cases, including smaller nested deletions, with a low false positive rate." @default.
• W4206616002 created "2022-01-25" @default.
• W4206616002 creator A5000622340 @default.
• W4206616002 creator A5002025934 @default.
• W4206616002 creator A5003891666 @default.
• W4206616002 creator A5006030834 @default.
• W4206616002 creator A5008445985 @default.
• W4206616002 creator A5010312725 @default.
• W4206616002 creator A5011145896 @default.
• W4206616002 creator A5015205115 @default.
• W4206616002 creator A5015551339 @default.
• W4206616002 creator A5016676764 @default.
• W4206616002 creator A5016984489 @default.
• W4206616002 creator A5027130287 @default.
• W4206616002 creator A5028099145 @default.
• W4206616002 creator A5029931806 @default.
• W4206616002 creator A5030836937 @default.
• W4206616002 creator A5032942449 @default.
• W4206616002 creator A5038074846 @default.
• W4206616002 creator A5041645978 @default.
• W4206616002 creator A5052298622 @default.
• W4206616002 creator A5061765723 @default.
• W4206616002 creator A5063035887 @default.
• W4206616002 creator A5064043401 @default.
• W4206616002 creator A5067345685 @default.
• W4206616002 creator A5077359985 @default.
• W4206616002 creator A5083132394 @default.
• W4206616002 creator A5083479324 @default.
• W4206616002 creator A5084508109 @default.
• W4206616002 creator A5088244425 @default.
• W4206616002 date "2022-07-01" @default.
• W4206616002 modified "2023-10-15" @default.
• W4206616002 title "Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome" @default.
• W4206616002 cites W1600681439 @default.
• W4206616002 cites W1823173687 @default.
• W4206616002 cites W1965573357 @default.
• W4206616002 cites W2003538821 @default.
• W4206616002 cites W2029965540 @default.
• W4206616002 cites W2033314910 @default.
• W4206616002 cites W2066918107 @default.
• W4206616002 cites W2068894833 @default.
• W4206616002 cites W2069401773 @default.
• W4206616002 cites W2117315526 @default.
• W4206616002 cites W2119528684 @default.
• W4206616002 cites W2129125677 @default.
• W4206616002 cites W2139926668 @default.
• W4206616002 cites W2144967747 @default.
• W4206616002 cites W2170212209 @default.
• W4206616002 cites W2253685848 @default.
• W4206616002 cites W2329465801 @default.
• W4206616002 cites W2460216815 @default.
• W4206616002 cites W2485046853 @default.
• W4206616002 cites W2594011841 @default.
• W4206616002 cites W2607030666 @default.
• W4206616002 cites W2734398877 @default.
• W4206616002 cites W2740669386 @default.
• W4206616002 cites W2767603088 @default.
• W4206616002 cites W2783699103 @default.
• W4206616002 cites W2788333152 @default.
• W4206616002 cites W2792966513 @default.
• W4206616002 cites W2805379439 @default.
• W4206616002 cites W2896487577 @default.
• W4206616002 cites W2899016780 @default.
• W4206616002 cites W3171229796 @default.
• W4206616002 cites W3193738716 @default.
• W4206616002 cites W4361868026 @default.
• W4206616002 doi "https://doi.org/10.1016/j.ajog.2022.01.002" @default.
• W4206616002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35033576" @default.
• W4206616002 hasPublicationYear "2022" @default.
• W4206616002 type Work @default.
• W4206616002 citedByCount "29" @default.
• W4206616002 countsByYear W42066160022022 @default.
• W4206616002 countsByYear W42066160022023 @default.
• W4206616002 crossrefType "journal-article" @default.
• W4206616002 hasAuthorship W4206616002A5000622340 @default.
• W4206616002 hasAuthorship W4206616002A5002025934 @default.
• W4206616002 hasAuthorship W4206616002A5003891666 @default.
• W4206616002 hasAuthorship W4206616002A5006030834 @default.
• W4206616002 hasAuthorship W4206616002A5008445985 @default.
• W4206616002 hasAuthorship W4206616002A5010312725 @default.
• W4206616002 hasAuthorship W4206616002A5011145896 @default.
• W4206616002 hasAuthorship W4206616002A5015205115 @default.
• W4206616002 hasAuthorship W4206616002A5015551339 @default.
• W4206616002 hasAuthorship W4206616002A5016676764 @default.
• W4206616002 hasAuthorship W4206616002A5016984489 @default.
• W4206616002 hasAuthorship W4206616002A5027130287 @default.
• W4206616002 hasAuthorship W4206616002A5028099145 @default.
• W4206616002 hasAuthorship W4206616002A5029931806 @default.
• W4206616002 hasAuthorship W4206616002A5030836937 @default.
• W4206616002 hasAuthorship W4206616002A5032942449 @default.
• W4206616002 hasAuthorship W4206616002A5038074846 @default.
• W4206616002 hasAuthorship W4206616002A5041645978 @default.
• W4206616002 hasAuthorship W4206616002A5052298622 @default.
• W4206616002 hasAuthorship W4206616002A5061765723 @default.
• W4206616002 hasAuthorship W4206616002A5063035887 @default.
• W4206616002 hasAuthorship W4206616002A5064043401 @default.
• W4206616002 hasAuthorship W4206616002A5067345685 @default.
• W4206616002 hasAuthorship W4206616002A5077359985 @default.

• next